All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

What is the role of current mass spectrometry in pharmaceutical analysis?

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22340%2F23%3A43926969" target="_blank" >RIV/60461373:22340/23:43926969 - isvavai.cz</a>

  • Result on the web

    <a href="https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/mas.21858" target="_blank" >https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/mas.21858</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/mas.21858" target="_blank" >10.1002/mas.21858</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    What is the role of current mass spectrometry in pharmaceutical analysis?

  • Original language description

    The role of mass spectrometry (MS) has become more important in most application domains in recent years. Pharmaceutical analysis is specific due to its stringent regulation procedures, the need for good laboratory/manufacturing practices, and a large number of routine quality control analyses to be carried out. The role of MS is, therefore, very different throughout the whole drug development cycle. While it dominates within the drug discovery and development phase, in routine quality control, the role of MS is minor and indispensable only for selected applications. Moreover, its role is very different in the case of analysis of small molecule pharmaceuticals and biopharmaceuticals. Our review explains the role of current MS in the analysis of both small-molecule chemical drugs and biopharmaceuticals. Important features of MS-based technologies being implemented, method requirements, and related challenges are discussed. The differences in analytical procedures for small molecule pharmaceuticals and biopharmaceuticals are pointed out. While a single method or a small set of methods is usually sufficient for quality control in the case of small molecule pharmaceuticals and MS is often not indispensable, a large panel of methods including extensive use of MS must be used for quality control of biopharmaceuticals. Finally, expected development and future trends are outlined.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10406 - Analytical chemistry

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Mass Spectrometry Reviews

  • ISSN

    0277-7037

  • e-ISSN

    1098-2787

  • Volume of the periodical

    neuveden

  • Issue of the periodical within the volume

    2023

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    50

  • Pages from-to

    1-50

  • UT code for WoS article

    001037413700001

  • EID of the result in the Scopus database

    2-s2.0-85165913551